VIVUS, Inc. (NASDAQ: VVUS) announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE